Addex Therapeutics Ltd (ADXN) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -765.84K | -608.4K | -533.2K | -419.84K | -598.71K | -23.56K | -398.58K | -2.76M | -2.19M | -623.02K | -2.25M | -2.76M | -2.36M | -3.07M | -2.69M | -5.83M | -4.84M | -2.94M | -2.54M | -6.45M |
| Operating CF Margin % | -9741.06% | -245322.98% | -1793.85% | -1154.2% | - | -1562.07% | -740.35% | -2391.66% | -939.31% | -406.01% | -687.18% | -437.14% | -471.05% | -518.51% | -657.15% | -3179.79% | -2042.1% | -740.87% | -372.28% | -650.06% |
| Operating CF Growth % | -27.92% | -2482.79% | -33.77% | 84.77% | 72.7% | 96.22% | 82.3% | 0.03% | 7.05% | 79.72% | 16.29% | 52.7% | 51.3% | -4.31% | -5.97% | 9.64% | -74.97% | -517.8% | 0.74% | -4.63% |
| Net Income | -1.71M | -1.82M | -1.58M | -1.84M | -1.47M | -1.21M | -1.53M | 12.88M | -3.09M | -2.86M | -2.62M | -2.68M | -2.41M | -3.65M | -4.11M | -7.22M | -5.82M | -4.42M | -3.6M | -4.69M |
| Depreciation & Amortization | 9.82K | 2.1K | 2.12K | 2.12K | 2.12K | 23.8K | 53.58K | 112.38K | 2.94K | 79.39K | 75.38K | 75.41K | 75.78K | 75.65K | 77.32K | 83.35K | 86.83K | 82.97K | 87.74K | 88.26K |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 | 31.26K | 38.45K | 47.23K | 386.03K | 389.21K | 483.46K | 490.6K | 431.2K | 684.77K | 898K | 659.26K | 1.44M | 274.33K | 381.06K | 336.85K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -389.21K | -5.27K | -9.15K | 0 | 0 | 0 | 0 | 0 | -11.54K | 38.85K | 12.02K |
| Other Non-Cash Items | 1.25M | 1.06M | 898.5K | 1.35M | 889.46K | 688.75K | 859.74K | -13.43M | -57.78K | 572.05K | -37.53K | 138.56K | -19.82K | 204.57K | -109.94K | 62.13K | 47.37K | 201.16K | 45.33K | 293.1K |
| Working Capital Changes | -315.52K | 152.87K | 143.41K | 73.92K | -17.42K | 438.37K | 179.62K | -2.36M | 562.85K | 1.58M | -151.1K | -778.09K | -439.43K | -385.2K | 551.78K | 586.24K | -595.15K | 932.16K | 506.22K | -2.48M |
| Change in Receivables | -11.9K | 29.61K | -12.81K | -3.08K | -19.85K | 501K | 99.92K | -471.4K | -73.78K | 73.91K | 71.39K | -25.24K | 186.46K | -119.2K | 34.1K | 35.05K | -202.04K | 34.25K | -72.59K | -53.28K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -638.69K | 685.02K | 572.09K | -5.21K | 791.11K | 303.71K | -445.18K | 0 | 0 | 0 | 0 |
| Change in Payables | 0 | 22.11K | 0 | 0 | 0 | -117.37K | -55.17K | -2.2M | 931.16K | 638.69K | -685.02K | -572.09K | 5.21K | -791.11K | -303.71K | 445.18K | 222.25K | 439.15K | -435.66K | -621.53K |
| Cash from Investing | 0 | -9.05K | 60.07K | -737.36K | 0 | -15.9K | -5.84K | 4.67M | 0 | -1.21K | -678 | -2.49K | -2.47K | -9 | 2.98K | 0 | 0 | -24.4K | -521 | -2.23K |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | -1.27K | 0 | 0 | -1.21K | -678 | -2.49K | -2.47K | 0 | -580 | 0 | 0 | -24.49K | -1.67K | -2.23K |
| CapEx % of Revenue | - | - | - | - | - | - | 2.36% | - | - | 0.79% | 0.21% | 0.39% | 0.49% | - | 0.14% | - | - | 6.16% | 0.24% | 0.23% |
| Acquisitions | 0 | -3.4K | 60.07K | 0 | 0 | -15.9K | -4.57K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -3.2K | 0 | -737.36K | 0 | 0 | 0 | 4.67M | 0 | 0 | 0 | 0 | 0 | -8 | 3.56K | 0 | 0 | 87 | 1.15K | 0 |
| Cash from Financing | 65.42K | 82.66K | 361.01K | 649.19K | 97.99K | -1.72K | -494 | -57.41K | 164.55K | -58.35K | -188.96K | 4.48M | 1.03M | -168.9K | 4.19M | -170.25K | -744.35K | 8.16M | -90.18K | -455.96K |
| Debt Issued (Net) | -1.55K | -1.86K | -1.84K | -1.81K | -1.79K | -1.77K | -2.18K | -3K | -66.73K | -69.05K | -72.13K | -26.6K | -114.02K | -66.97K | -70.13K | -75.92K | -75.06K | -73.9K | -78.68K | -79.44K |
| Equity Issued (Net) | 70.33K | 84.5K | 363.45K | -25.9K | 100.33K | 240.9K | 2.65K | -236.79K | -4.55K | 1.19M | -60.59K | -17.98K | 1.18M | 80 | 1.22M | 8.56K | -8.56K | 3.74M | 407 | 28.34K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -3.18K | 0 | -2.75K | -25.9K | 0 | 0 | 0 | 0 | -4.55K | 0 | -18.34K | -15.23K | 0 | 0 | 0 | -5.03K | -8.56K | 0 | 0 | 0 |
| Other Financing | -3.35K | 28 | -596 | 676.91K | -548 | -240.85K | 1.68K | 182.38K | 235.83K | -1.18M | -116.83K | 4.53M | -35.38K | -102.01K | 3.03M | -102.89K | -660.73K | 4.49M | -11.9K | -404.86K |
| Net Change in Cash | -703.46K | -539.86K | -113.79K | -524.49K | -516.25K | -7.44K | -438.6K | 2.16M | -2.24M | -888.63K | -2.41M | 1.57M | -1.36M | -3.47M | 1.61M | -6.07M | -5.6M | 5M | -2.62M | -7.11M |
| Free Cash Flow | -765.84K | -608.4K | -533.2K | -419.84K | -598.71K | -23.56K | -399.86K | -2.76M | -2.19M | -624.23K | -2.25M | -2.76M | -2.36M | -3.07M | -2.69M | -5.83M | -4.84M | -2.97M | -2.54M | -6.45M |
| FCF Margin % | -9741.06% | -245322.98% | -1793.85% | -1154.2% | - | -1562.07% | -742.72% | -2391.66% | -939.31% | -406.79% | -687.39% | -437.54% | -471.54% | -518.51% | -657.29% | -3179.79% | -2042.1% | -747.03% | -372.53% | -650.28% |
| FCF Growth % | -27.92% | -2482.79% | -33.35% | 84.77% | 72.7% | 96.23% | 82.25% | 0.12% | 7.15% | 79.68% | 16.29% | 52.66% | 51.25% | -3.45% | -5.92% | 9.67% | -74.77% | -552.12% | 0.7% | -4.63% |
| FCF per Share | -0.54 | -0.51 | -0.57 | -0.55 | -0.73 | -0.03 | -0.49 | -3.39 | -2.70 | -0.79 | -3.50 | -4.59 | -4.63 | -6.17 | -6.76 | -18.67 | -15.34 | -10.25 | -8.93 | -22.74 |
| FCF Conversion (FCF/Net Income) | 0.45x | 0.33x | 0.34x | 0.23x | 0.41x | 0.02x | 0.26x | -0.21x | 0.71x | 0.22x | 0.86x | 1.03x | 0.98x | 0.84x | 0.65x | 0.81x | 0.83x | 0.67x | 0.71x | 1.38x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |